- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.12. | Spotlight Stock Market: Market Notice 271/24 - Information regarding the rights issue from BibbInstruments AB | 2 | Cision News | ||
| 25.11. | BIBBINSTRUMENTS AB: Clinical evaluation at Karolinska University Hospital is progressing | 1 | Cision News | ||
| 19.11. | BIBBINSTRUMENTS AB: BiBBInstrument' founder on the Sahlgrenska evaluation | 1 | Cision News | ||
| 15.11. | BIBBINSTRUMENTS AB: Well-executed clinical introduction of EndoDrill[®] GI at Sahlgrenska University Hospital in Sweden | 1 | Cision News | ||
| 13.11. | BIBBINSTRUMENTS AB: BiBB has initiated a collaboration with Swedish contract manufacturer Cenova | 1 | Cision News | ||
| 12.11. | BIBBINSTRUMENTS AB: BiBBInstrument's CEO to "Distributors are contacting us" | 2 | Cision News | ||
| 30.10. | BIBBINSTRUMENTS AB: Impressive US Clinical Case Series presented at ACG 2024 in Philadelphia | 2 | Cision News | ||
| BIBBINSTRUMENTS Aktie jetzt für 0€ handeln | |||||
| 11.10. | BIBBINSTRUMENTS AB: BiBB receives an Intention to Grant for EndoDrill patent in China | 1 | Cision News | ||
| 27.09. | BIBBINSTRUMENTS AB: BiBB comments on the growing interest in EndoDrill GI | 2 | Cision News | ||
| 24.09. | BIBBINSTRUMENTS AB: EndoDrill GI sparks interest at the 7th Nordic EUS Meeting in Copenhagen | 2 | Cision News | ||
| 06.09. | BIBBINSTRUMENTS AB: BiBB's CEO to "Zagreb confirms good samples and short learning curve" | 1 | Cision News | ||
| 04.09. | BIBBINSTRUMENTS AB: BiBB receives an Intention to Grant for EndoDrill patent in Europe | 1 | Cision News | ||
| 02.09. | BIBBINSTRUMENTS AB: Successful introduction of EndoDrill GI at University Hospital Center Sestre Milosrdnice in Zagreb, Croatia | 1 | Cision News |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROGYNY | 14,710 | 0,00 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| GENEDX | 79,45 | +2,65 % | GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial results for the third... ► Artikel lesen | |
| CASTLE BIOSCIENCES | 27,100 | -2,24 % | Castle Biosciences plant Markteinführung von Neurodermitis-Test bis Ende 2025 | ||
| NANO-X IMAGING | 7,530 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| MIMEDX | 9,390 | +2,85 % | MiMedx Group, Inc: MIMEDX Announces Third Quarter 2024 Operating and Financial Results | Net Sales of $84 million Grew 3% Year-Over-Year for the Third QuarterThird Quarter GAAP Net Income and Earnings Per Share were $8 Million and $0.05, RespectivelyThird Quarter Adjusted EBITDA was $18... ► Artikel lesen | |
| RXSIGHT | 35,040 | +1,65 % | RxSight cut to hold at Stifel on competition concerns | ||
| PROCEPT BIOROBOTICS | 83,62 | -0,12 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ADAPTHEALTH | 9,780 | -2,69 % | AdaptHealth Corp. Announces Third Quarter 2024 Results | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| GOODRX | 4,520 | 0,00 % | GoodRx Reports Third Quarter 2024 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading prescription savings platform in the U.S., has released... ► Artikel lesen | |
| EUROPEAN WAX CENTER | 6,160 | +15,36 % | European Wax Center, Inc. Reports Third Quarter Fiscal Year 2024 Results | Reiterates fiscal 2024 financial outlook Updates fiscal 2024 outlook for net new centers Third Quarter Fiscal 2024 versus 2023 Net new centers increased 3.7% to 1,064 total centers in 45 statesSystem-wide... ► Artikel lesen | |
| TALKSPACE | 3,220 | +6,62 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| ATRICURE | 30,750 | +0,82 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 10,835 | +1,07 % | Alignment Healthcare Reports Third Quarter 2024 Results | Reports $692.4 million in total revenue, up 51.6% year-over-year Increases Medicare Advantage membership, up 57.7% year-over-year to approximately 182,300 members, beating third-quarter and year-end... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,430 | +1,92 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| CLEARPOINT NEURO | 16,480 | +4,93 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain | Only Device Approved to Deliver First Disease-Modifying Treatment for AADC Deficiency in the United StatesSOLANA BEACH, CA / ACCESSWIRE / November 13, 2024 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the... ► Artikel lesen |
Das Unternehmen BIBBINSTRUMENTS AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +10,28 % bei einem Aktienkurs von 0,279 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIBBINSTRUMENTS AB finden Sie auf Wallstreet Online.
